Location: Greenwich, CT
CIK: 0001802630 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Apr 29, 2021
Total Value: $758M (98.5% shares, 1.5% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 2,825,000 | $398M | 52.5% | — | — | Put | 78464A870 |
| BCAB | BIOATLA INC | 3,179,362 | $108M | 14.3% | $33.43 | 0.0% | COM | 09077B104 |
| — | ESSA PHARMA INC | 2,375,681 | $28.34M | 3.7% | $6.74 | — | COM NEW | 29668H708 |
| — | GALECTO INC | 1,512,648 | $18.92M | 2.5% | $12.51 | — | COM | 36322Q107 |
| — | IVERIC BIO INC | 1,597,279 | $11.04M | 1.5% | $5.57 | — | COM | 46583P102 |
| — | INVITAE CORP | 244,760 | $10.23M | 1.4% | $41.81 | — | COM | 46185L103 |
| LNTH | LANTHEUS HLDGS INC | 742,085 | $10.01M | 1.3% | $13.52 | -3.2% | COM | 516544103 |
| CCCC | C4 THERAPEUTICS INC | 268,548 | $8.897M | 1.2% | $29.00 | 0.0% | COM STK | 12529R107 |
| — | IONIS PHARMACEUTICALS INC | 8,500,000 | $8.675M | 1.1% | $1.02 | — | NOTE 0.125%12/1 | 462222AB6 |
| XENE | XENON PHARMACEUTICALS INC | 558,117 | $8.584M | 1.1% | $12.14 | -3.6% | COM | 98420N105 |
| EXEL | EXELIXIS INC | 390,847 | $7.844M | 1.0% | $20.93 | 0.0% | COM | 30161Q104 |
| NTRA | NATERA INC | 74,189 | $7.383M | 1.0% | $56.85 | +47.0% | COM | 632307104 |
| VCEL | VERICEL CORP | 236,589 | $7.305M | 1.0% | $16.21 | +46.8% | COM | 92346J108 |
| — | INHIBRX INC | 213,807 | $7.049M | 0.9% | $18.00 | — | COM | 45720L107 |
| IRMD | IRADIMED CORP | 303,998 | $6.931M | 0.9% | $21.38 | -1.2% | COM | 46266A109 |
| — | TCR2 THERAPEUTICS INC | 199,867 | $6.182M | 0.8% | $20.32 | — | COM | 87808K106 |
| — | DARIOHEALTH CORP | 401,606 | $5.739M | 0.8% | $14.29 | — | COM NEW | 23725P209 |
| — | MERSANA THERAPEUTICS INC | 206,844 | $5.504M | 0.7% | $18.62 | — | COM | 59045L106 |
| — | LYRA THERAPEUTICS INC | 456,138 | $5.199M | 0.7% | $11.36 | — | COM | 55234L105 |
| SPRY | SILVERBACK THERAPEUTICS INC | 107,826 | $4.997M | 0.7% | $33.40 | 0.0% | COM | 82835W108 |
| — | VESPER HEALTHCARE ACQSTN COR | 416,551 | $4.711M | 0.6% | $11.31 | — | COM CL A | 92538T104 |
| NVCR | NOVOCURE LTD | 24,999 | $4.326M | 0.6% | $67.08 | +104.0% | ORD SHS | G6674U108 |
| — | OAKTREE ACQUISITION CORP | 281,565 | $4.111M | 0.5% | $14.60 | — | SHS CL A | G67145105 |
| — | SURMODICS INC | 92,975 | $4.046M | 0.5% | $41.73 | — | COM | 868873100 |
| — | MISONIX INC | 301,333 | $3.767M | 0.5% | $14.84 | — | COM | 604871103 |
| AZN | ASTRAZENECA PLC | 64,284 | $3.214M | 0.4% | $50.41 | — | SPONSORED ADR | 046353108 |
| DXCM | DEXCOM INC | 8,165 | $3.018M | 0.4% | $50.41 | +77.1% | COM | 252131107 |
| — | ALEXION PHARMACEUTICALS INC | 18,938 | $2.959M | 0.4% | $102.42 | — | COM | 015351109 |
| — | ITAMAR MED LTD | 140,524 | $2.791M | 0.4% | $13.02 | — | SPONSORED ADS | 465437101 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 66,921 | $2.519M | 0.3% | $26.35 | 0.0% | COM | G31249108 |
| — | GOSSAMER BIO INC | 2,750,000 | $2.477M | 0.3% | $0.94 | — | NOTE 5.000% 6/0 | 38341PAA0 |
| NEO | NEOGENOMICS INC | 45,951 | $2.474M | 0.3% | $45.19 | 0.0% | COM NEW | 64049M209 |
| RFL | RAFAEL HLDGS INC | 104,737 | $2.442M | 0.3% | $17.19 | +14.5% | COM CL B | 75062E106 |
| MRK | MERCK & CO. INC | 28,406 | $2.324M | 0.3% | $65.86 | -1.5% | COM | 58933Y105 |
| — | TURNING POINT THERAPEUTICS I | 19,013 | $2.317M | 0.3% | $121.86 | — | COM | 90041T108 |
| ABBV | ABBVIE INC | 21,477 | $2.301M | 0.3% | $78.94 | 0.0% | COM | 00287Y109 |
| — | EIGER BIOPHARMACEUTICALS INC | 185,719 | $2.282M | 0.3% | $10.45 | — | COM | 28249U105 |
| CMPS | COMPASS PATHWAYS PLC | 42,743 | $2.036M | 0.3% | $34.90 | — | SPONSORED ADS | 20451W101 |
| — | ONCORUS INC | 56,422 | $1.824M | 0.2% | $32.33 | — | COM | 68236R103 |
| — | PROVENTION BIO INC | 105,941 | $1.795M | 0.2% | $13.38 | — | COM | 74374N102 |
| — | MIRATI THERAPEUTICS INC | 7,838 | $1.722M | 0.2% | $219.70 | — | COM | 60468T105 |
| — | OAK STR HEALTH INC | 27,612 | $1.689M | 0.2% | $53.44 | — | COM | 67181A107 |
| — | NEVRO CORP | 9,589 | $1.66M | 0.2% | $119.47 | — | COM | 64157F103 |
| CRSP | CRISPR THERAPEUTICS AG | 10,825 | $1.657M | 0.2% | $58.44 | +102.3% | NAMEN AKT | H17182108 |
| — | TRILLIUM THERAPEUTICS INC | 103,819 | $1.527M | 0.2% | $14.21 | — | COM NEW | 89620X506 |
| — | ADVERUM BIOTECHNOLOGIES INC | 135,992 | $1.474M | 0.2% | $11.03 | — | COM | 00773U108 |
| — | KADMON HLDGS INC | 336,442 | $1.396M | 0.2% | $4.38 | — | COM | 48283N106 |
| — | MIRAGEN THERAPEUTICS INC | 81,185 | $1.335M | 0.2% | $16.44 | — | COM NEW | 60463E202 |
| — | PIERIS PHARMACEUTICALS INC | 500,000 | $1.25M | 0.2% | $2.07 | — | COM | 720795103 |
| SRRK | SCHOLAR ROCK HLDG CORP | 24,484 | $1.188M | 0.2% | $36.31 | 0.0% | COM | 80706P103 |
| — | ZYMEWORKS INC | 22,631 | $1.07M | 0.1% | $36.52 | — | COM | 98985W102 |
| CRDF | CARDIFF ONCOLOGY INC | 56,909 | $1.024M | 0.1% | $6.60 | +166.2% | COM | 14147L108 |
| BIIB | BIOGEN INC | 3,899 | $955K | 0.1% | $278.63 | -7.0% | COM | 09062X103 |
| — | HORIZON THERAPEUTICS PUB L | 12,655 | $926K | 0.1% | $65.15 | — | SHS | G46188101 |
| — | REVANCE THERAPEUTICS INC | 31,136 | $882K | 0.1% | $22.30 | — | COM | 761330109 |
| MDNAF | MEDICENNA THERAPEUTICS CORP | 186,799 | $874K | 0.1% | $4.05 | -0.6% | COM | 58490H107 |
| KYMR | KYMERA THERAPEUTICS INC | 13,116 | $813K | 0.1% | $30.53 | +59.8% | COM | 501575104 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 7,661 | $657K | 0.1% | $85.76 | — | COM | G11196105 |
| KRYS | KRYSTAL BIOTECH INC | 10,423 | $625K | 0.1% | $49.94 | 0.0% | COM | 501147102 |
| FATE | FATE THERAPEUTICS INC | 6,830 | $621K | 0.1% | $29.80 | +108.4% | COM | 31189P102 |
| AXGN | AXOGEN INC | 33,813 | $605K | 0.1% | $13.27 | +10.7% | COM | 05463X106 |
| — | ALPINE IMMUNE SCIENCES INC | 41,064 | $517K | 0.1% | $12.59 | — | COM | 02083G100 |
| TARA | PROTARA THERAPEUTICS INC | 16,093 | $390K | 0.1% | $23.19 | -7.0% | COM STK | 74365U107 |
| — | OAKTREE ACQUISITION CORP | 91,793 | $358K | 0.0% | $3.90 | — | *W EXP 99/99/999 | G67145113 |
| STAA | STAAR SURGICAL CO | 3,300 | $261K | 0.0% | $37.85 | +93.3% | COM PAR $0.01 | 852312305 |